Welcome to LookChem.com Sign In|Join Free
  • or
The β-cyclodextrin-warfarin complex is a chemical combination formed between β-cyclodextrin, a cyclic oligosaccharide consisting of seven glucose units, and warfarin, a widely used anticoagulant drug. This complexation occurs due to the ability of β-cyclodextrin to form inclusion complexes with various guest molecules, such as warfarin, through its hydrophobic cavity. The formation of this complex can potentially enhance the solubility, stability, and bioavailability of warfarin, while also reducing its toxicity and side effects. The β-cyclodextrin-warfarin complex has been studied for its potential applications in drug delivery systems, as it can improve the pharmacokinetic and pharmacodynamic properties of warfarin, making it a promising candidate for further research and development in the field of pharmaceuticals.

69441-12-9

Post Buying Request

69441-12-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

69441-12-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 69441-12-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,4,4 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 69441-12:
(7*6)+(6*9)+(5*4)+(4*4)+(3*1)+(2*1)+(1*2)=139
139 % 10 = 9
So 69441-12-9 is a valid CAS Registry Number.

69441-12-9Downstream Products

69441-12-9Relevant academic research and scientific papers

Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery

Khalil, Safaa K.H.,El-Feky, Gina S.,El-Banna, Sally T.,Khalil, Wafaa A.

, p. 1244 - 1253 (2012)

The main objective of the present work was to prepare warfarin-β- cyclodextrin (WAF-β-CD) loaded chitosan (CS) nanoparticles for transdermal delivery. CS is a hydrophilic carrier therefore, to overcome the hydrophobic nature of WAF and allow its incorporation into CS nanoparticles, WAF was first complexed with β-cyclodextrin (β-CD). CS nanoparticles were prepared by ionotropic pre-gelation using tripolyphosphate (TPP). Morphology, size and structure characterization of nanoparticles were carried out using SEM, TEM and FTIR, respectively. Nanoparticles prepared with 3:1 CS:TPP weight ratio and 2 mg/ml final CS concentration were found optimum. They possessed spherical particles (35 ± 12 nm diameter) with narrow size distribution (PDI = 0.364) and 94% entrapment efficiency. The in vitro release as well as the ex vivo permeation profiles of WAF-β-CD from the selected nanoparticle formulation were studied at different time intervals up to 8 h. In vitro release of WAF-β-CD from CS nanoparticles followed a Higuchi release profile whereas its ex vivo permeation (at pH 7.4) followed a zero order permeation profile. Results suggested that the developed WAF-β-CD loaded CS carrier could offer a controlled and constant delivery of WAF transdermally.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 69441-12-9